Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Zealand Pharma receives milestone payment from Helsinn Healthcare regarding ZP-1846

Dec. 14, 2010

Merck & Co. claims new inhibitors of kinesin-like protein KIF11

Dec. 14, 2010

Novel inhibitors of M-phase inducer phosphatase 3 claimed

Dec. 14, 2010

Eisai launches anticancer agent Treakisym in Japan

Dec. 14, 2010

Nerviano discloses promising preclinical/clinical data on new oncolytic compounds

Dec. 14, 2010

Kinase inhibitors from Bayer show oncolytic activity alone and in combination

Dec. 14, 2010

Phase I and preclinical data presented on PD-0332991 in multiple myeloma

Dec. 14, 2010

BioVex begins phase III trial of OncoVex(GM-CSF) in head and neck cancer

Dec. 13, 2010

Oncolytic agent S-110 shows promising preclinical results and advances into clinic

Dec. 13, 2010

Adding ganitumab to exemestane or fulvestrant does not improve PFS in patients with breast cancer

Dec. 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...